Novo Nordisk Hemophilia Drug Flouts Patent, ITC Judge Says
An International Trade Commission judge has ruled that Novo Nordisk AS infringed a Baxalta Inc. patent that is part of a larger investigation into whether Baxter can block allegedly infringing imports...To view the full article, register now.
Already a subscriber? Click here to view full article